Jyoti Vishnu Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 29-12-2024
- Paid Up Capital ₹ 1.10 Cr
as on 29-12-2024
- Company Age 47 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 29-12-2024
- Satisfied Charges ₹ 5.66 Cr
as on 29-12-2024
- Revenue 64.58%
(FY 2022)
- Profit 99.92%
(FY 2022)
- Ebitda 95.20%
(FY 2022)
- Net Worth 3.96%
(FY 2022)
- Total Assets -2.57%
(FY 2022)
About Jyoti Vishnu Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.10 Cr.
The company currently has active open charges totaling ₹4.50 M. The company has closed loans amounting to ₹5.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suresh Gupta and Nitin Gupta serve as directors at the Company.
- CIN/LLPIN
U24239TG1977PTC002192
- Company No.
002192
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 1977
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jyoti Vishnu Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Gupta  | Director | 20-Sep-2010 | Current |
| Suresh Gupta | Director | 21-Apr-1979 | Current |
Financial Performance of Jyoti Vishnu Pharma.
Jyoti Vishnu Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 64.58% increase. The company also saw a substantial improvement in profitability, with a 99.92% increase in profit. The company's net worth moved up by a moderate rise of 3.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jyoti Vishnu Pharma?
Unlock access to Jyoti Vishnu Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 18 Nov 2024 | ₹4.50 M | Open |
Citi Bank N.A. Creation Date: 28 Jul 2010 | ₹3.80 Cr | Satisfied |
Syndicate Bank Creation Date: 26 May 2008 | ₹1.84 Cr | Satisfied |
How Many Employees Work at Jyoti Vishnu Pharma?
Jyoti Vishnu Pharma has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jyoti Vishnu Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jyoti Vishnu Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
